Rhythm Pharmaceuticals buy Royal Bank of Canada
Start price
17.03.26
/
50%
€77.50
Target price
17.03.27
€113.07
Performance (%)
-1.29%
Price
12.06.26
€74.50
Summary
This prediction is currently active. With a performance of -1.29%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 17.03.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | -0.667% | -0.667% |
| iShares Core DAX® | 0,27 % | 2,50 % |
| iShares Nasdaq 100 | 1,88 % | 3,49 % |
| iShares Nikkei 225® | 3,58 % | 8,13 % |
| iShares S&P 500 | 0,15 % | 1,92 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Royal Bank Of Canada from $140.00 to $130.00. They now have an "outperform" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€81.00
06.05.26
06.05.26
€116.89
06.05.27
06.05.27
-5.56%
12.06.26
12.06.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€84.50
18.02.26
18.02.26
-
18.02.27
18.02.27
-11.83%
12.06.26
12.06.26